Artivion | CRY - Operating Expenses


Artivion reported $111.2M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 150.1M 6.16M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Inogen USD 49.14M 665K Sep/2024
Integra LifeSciences USD 368.53M 674.84M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Pfizer USD 89B 3.81B Sep/2026
ResMed USD 1.01B 83.57M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 286.06M 17.71M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Terumo JPY 331.37B 109.04B Sep/2026
Trinity Biotech USD 12.63M 255K Mar/2026